arrow_back Back Filing freshness 10-Q Q1 FY2027 SEC EDGAR

Prestige Consumer Healthcare Inc.

PBH
$44.33 ▼ -8.98 (-16.85%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
67 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Bullish
auto_awesome

Analytical Summary

Prestige Consumer Healthcare Inc. shows strong fundamentals with top-quartile Profit Margin (%) and Operating Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $2.1B
Dividend Yield —
Revenue Growth 6.5% ↗
Op. Margin 19.8% ↘
ROIC 1.1% ↘
FCF / Share $1.41
Trailing P/E 72.7x
Price / Book 1.1x
FCF Yield 3.2%
Debt / Equity 1.05
info Valuation on last close. End-of-day price, Nov 5, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$265.71M
↑ +6.5% —
Net Income Profit after all expenses
$29.18M
↓ -38.5% —
Operating Margin Operating profit as % of sales
19.8%
↓ -26.3% 92th
FCF / Share Free cash flow per share
$1.41
↓ -10.5% —
Long-Term Debt Long-term obligations
$2.01B
↑ +101.9% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
  • Profit Margin (%)Profit Margin (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability ↓
86
Returns ↓
62
Financial Health →
56
Cash Quality ↑
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 18 years · 67 quarters